Skip to main content
Erschienen in: Drugs & Aging 9/2005

01.09.2005 | Original Research Article

Use of Psychotropic Drugs in Elderly Nursing Home Residents with and without Dementia in Helsinki, Finland

verfasst von: Helka Hosia-Randell, Dr Kaisu Pitkälä

Erschienen in: Drugs & Aging | Ausgabe 9/2005

Einloggen, um Zugang zu erhalten

Abstract

Objective

Use of psychotropic medication is very common in nursing home residents. Our objective was to describe the use of psychotropic drugs in all long-term nursing home residents ≥65 years of age with and without dementia in Helsinki, Finland.

Method

The study was a cross-sectional assessment of the nursing home population. The residents’ health status was assessed and data on their demographic factors, health and medication use were collected from medical charts in February 2003.

Results

Of all nursing home residents in Helsinki, 82% (n = 1987) participated in the study. The nursing home residents’ mean age was 83.7 (SD 7.7) years, 80.7% were female, and 69.5% were diagnosed with dementia. The mean number of psychotropic drugs given regularly was 7.9 (SD 3.6) per resident. Of the participants, 79.7% were regularly taking psychotropic medication. Conventional antipsychotics were administered to 18.9% of residents and atypical antipsychotics to 27.0%. Of the residents, 26.7% were on selective serotonin reuptake inhibitors (SSRIs), 3.1% on tricyclic antidepressants and 17.6% on other antidepressants. Altogether, 44.6% of residents were taking one or more antidepressant. More than a quarter (26.3%) were taking at least one anxiolytic drug. Hypnotics were used by 27.5%. However, only moderate dosages of psychotropic drugs were being taken. Only 10.4% of individuals with dementia were regularly taking cholinesterase inhibitors and four residents were taking memantine.

Conclusions

Use of psychotropic drugs is very common in nursing homes in Helsinki, Finland, with four of five nursing home residents regularly receiving psychotropic drugs. Only one in ten residents were receiving cholinesterase inhibitors. Physicians caring for nursing home residents require further education on the benefits and adverse effects of psychotropic drugs in frail elderly people.
Literatur
1.
Zurück zum Zitat Snowdon J, Vaughan R, Miller R, et al. Psychotropic drug use in Sydney nursing homes. Med J Aust 1995; 163(2): 70–2PubMed Snowdon J, Vaughan R, Miller R, et al. Psychotropic drug use in Sydney nursing homes. Med J Aust 1995; 163(2): 70–2PubMed
2.
Zurück zum Zitat McGrath AM, Jackson GA. Survey of neuroleptic prescribing in residents of nursing homes in Glasgow. BMJ 1996; 312(7031): 611–2PubMedCrossRef McGrath AM, Jackson GA. Survey of neuroleptic prescribing in residents of nursing homes in Glasgow. BMJ 1996; 312(7031): 611–2PubMedCrossRef
3.
Zurück zum Zitat Llorente MD, Olsen EJ, Leyva O, et al. Use of antipsychotic drugs in nursing homes: current compliance with OBRA regulations. J Am Geriatr Soc 1998; 46(2): 198–201PubMed Llorente MD, Olsen EJ, Leyva O, et al. Use of antipsychotic drugs in nursing homes: current compliance with OBRA regulations. J Am Geriatr Soc 1998; 46(2): 198–201PubMed
4.
Zurück zum Zitat Lasser RA, Sunderland T. Newer psychotropic medication use in nursing home residents. J Am Geriatr Soc 1998; 46(2): 202–7PubMed Lasser RA, Sunderland T. Newer psychotropic medication use in nursing home residents. J Am Geriatr Soc 1998; 46(2): 202–7PubMed
5.
Zurück zum Zitat Snowdon J. A follow-up survey of psychotropic drug use in Sydney nursing homes. Med J Aust 1999; 170(7): 299–301PubMed Snowdon J. A follow-up survey of psychotropic drug use in Sydney nursing homes. Med J Aust 1999; 170(7): 299–301PubMed
6.
Zurück zum Zitat van Dijk KN, de Vries CS, van den Berg PB, et al. Drug utilisation in Dutch nursing homes. Eur J Clin Pharmacol 2000 Jan; 55(10): 765–71PubMedCrossRef van Dijk KN, de Vries CS, van den Berg PB, et al. Drug utilisation in Dutch nursing homes. Eur J Clin Pharmacol 2000 Jan; 55(10): 765–71PubMedCrossRef
7.
Zurück zum Zitat Ruths S, Straand J, Nygaard HA. Psychotropic drug use in nursing homes: diagnostic indications and variations between institutions. Eur J Clin Pharmacol 2001; 57(6–7): 523–8PubMed Ruths S, Straand J, Nygaard HA. Psychotropic drug use in nursing homes: diagnostic indications and variations between institutions. Eur J Clin Pharmacol 2001; 57(6–7): 523–8PubMed
8.
Zurück zum Zitat Sorensen L, Foldspang A, Gulmann NC, et al. Determinants for the use of psychotropics among nursing home residents. Int J Geriatr Psychiatry 2001; 16(2): 147–54PubMedCrossRef Sorensen L, Foldspang A, Gulmann NC, et al. Determinants for the use of psychotropics among nursing home residents. Int J Geriatr Psychiatry 2001; 16(2): 147–54PubMedCrossRef
9.
Zurück zum Zitat Nilsson L, Petersson C. Consumption of psychopharmaceuticals in residential facilities for the elderly: evaluation of the extent, indications and effects [in Swedish]. Lakartidningen 2001; 98(12): 1371–3PubMed Nilsson L, Petersson C. Consumption of psychopharmaceuticals in residential facilities for the elderly: evaluation of the extent, indications and effects [in Swedish]. Lakartidningen 2001; 98(12): 1371–3PubMed
10.
Zurück zum Zitat Draper B, Brodaty H, Low LF, et al. Use of psychotropics in Sydney nursing homes: associations with depression, psychosis, and behavioral disturbances. Int Psychogeriatr 2001; 13(1): 107–20PubMedCrossRef Draper B, Brodaty H, Low LF, et al. Use of psychotropics in Sydney nursing homes: associations with depression, psychosis, and behavioral disturbances. Int Psychogeriatr 2001; 13(1): 107–20PubMedCrossRef
11.
Zurück zum Zitat Ford GA, Ballard C, Thomas SH. Anti-psychotic drug use in older people. Age Ageing 2002; 31(4): 225–6PubMedCrossRef Ford GA, Ballard C, Thomas SH. Anti-psychotic drug use in older people. Age Ageing 2002; 31(4): 225–6PubMedCrossRef
12.
Zurück zum Zitat Oborne CA, Hooper R, Li KC, et al. An indicator of appropriate neuroleptic prescribing in nursing homes. Age Ageing 2002; 31(6): 435–9PubMedCrossRef Oborne CA, Hooper R, Li KC, et al. An indicator of appropriate neuroleptic prescribing in nursing homes. Age Ageing 2002; 31(6): 435–9PubMedCrossRef
13.
Zurück zum Zitat Liperoti R, Mor V, Lapane KL, et al. The use of atypical antipsychotics in nursing homes. J Clin Psychiatry 2003; 64(9): 1106–12PubMedCrossRef Liperoti R, Mor V, Lapane KL, et al. The use of atypical antipsychotics in nursing homes. J Clin Psychiatry 2003; 64(9): 1106–12PubMedCrossRef
14.
Zurück zum Zitat Mamun K, Goh-Tan CY, Ng LL. Prescribing psychoactive medications in nursing homes: current practice in Singapore. Singapore Med J 2003; 44(12): 625–9PubMed Mamun K, Goh-Tan CY, Ng LL. Prescribing psychoactive medications in nursing homes: current practice in Singapore. Singapore Med J 2003; 44(12): 625–9PubMed
15.
Zurück zum Zitat Holmquist IB, Svensson B, Hoglund P. Psychotropic drugs in nursing- and old-age homes: relationships between needs of care and mental health status. Eur J Clin Pharmacol 2003; 59(8–9): 669–76PubMedCrossRef Holmquist IB, Svensson B, Hoglund P. Psychotropic drugs in nursing- and old-age homes: relationships between needs of care and mental health status. Eur J Clin Pharmacol 2003; 59(8–9): 669–76PubMedCrossRef
16.
Zurück zum Zitat Phillips VL, Diwan S. The incremental effect of dementiarelated problem behaviors on the time to nursing home placement in poor, frail, demented older people. J Am Geriatr Soc 2003; 51(2): 188–93PubMedCrossRef Phillips VL, Diwan S. The incremental effect of dementiarelated problem behaviors on the time to nursing home placement in poor, frail, demented older people. J Am Geriatr Soc 2003; 51(2): 188–93PubMedCrossRef
17.
Zurück zum Zitat Avorn J, Gurwitz JH. Drug use in the nursing home. Ann Intern Med 1995; 123(3): 195–204PubMed Avorn J, Gurwitz JH. Drug use in the nursing home. Ann Intern Med 1995; 123(3): 195–204PubMed
18.
Zurück zum Zitat Snowden M, Roy-Byrne P. Mental illness and nursing home reform: OBRA-87 ten years later. Omnibus Budget Reconciliation Act. Psychiatr Serv 1998; 49(2): 229–33PubMed Snowden M, Roy-Byrne P. Mental illness and nursing home reform: OBRA-87 ten years later. Omnibus Budget Reconciliation Act. Psychiatr Serv 1998; 49(2): 229–33PubMed
19.
Zurück zum Zitat Leipzig RM, Cumming RG, Tinetti ME. Drugs and falls in older people: a systematic review and meta-analysis: I. Psychotropic drugs. J Am Geriatr Soc 1999; 47(1): 30–9PubMed Leipzig RM, Cumming RG, Tinetti ME. Drugs and falls in older people: a systematic review and meta-analysis: I. Psychotropic drugs. J Am Geriatr Soc 1999; 47(1): 30–9PubMed
20.
Zurück zum Zitat Cumming RG. Epidemiology of medication-related falls and fractures in the elderly. Drugs Aging 1998; 12(1): 43–53PubMedCrossRef Cumming RG. Epidemiology of medication-related falls and fractures in the elderly. Drugs Aging 1998; 12(1): 43–53PubMedCrossRef
21.
Zurück zum Zitat Gurwitz JH, Field TS, Avorn J, et al. Incidence and preventability of adverse drug events in nursing homes. Am J Med 2000; 109(2): 87–94PubMedCrossRef Gurwitz JH, Field TS, Avorn J, et al. Incidence and preventability of adverse drug events in nursing homes. Am J Med 2000; 109(2): 87–94PubMedCrossRef
22.
Zurück zum Zitat Jeste DV, Rockwell E, Harris MJ, et al. Conventional vs newer antipsychotics in elderly patients. Am J Geriatr Psychiatry 1999; 7(1): 70–6PubMed Jeste DV, Rockwell E, Harris MJ, et al. Conventional vs newer antipsychotics in elderly patients. Am J Geriatr Psychiatry 1999; 7(1): 70–6PubMed
23.
Zurück zum Zitat Fick DM, Cooper JW, Wade WE, et al. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med 2003 Dec; 163(22): 2716–24PubMedCrossRef Fick DM, Cooper JW, Wade WE, et al. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med 2003 Dec; 163(22): 2716–24PubMedCrossRef
24.
Zurück zum Zitat Noro A, Finne-Soveri H, Björkgren M, et al. Quality and productivity in institutional care for elderly residents: benchmarking with the RAI. 1st ed. Helsinki: National Research and Development Centre for Welfare and Health (STAKES), 2005 Noro A, Finne-Soveri H, Björkgren M, et al. Quality and productivity in institutional care for elderly residents: benchmarking with the RAI. 1st ed. Helsinki: National Research and Development Centre for Welfare and Health (STAKES), 2005
25.
Zurück zum Zitat Pedone C, Lapane KL, Mor V, et al. Donepezil use in US nursing homes. Aging Clin Exp Res 2004; 16(1): 60–7PubMed Pedone C, Lapane KL, Mor V, et al. Donepezil use in US nursing homes. Aging Clin Exp Res 2004; 16(1): 60–7PubMed
26.
Zurück zum Zitat Suominen M, Muurinen S, Routasalo P, et al. Malnutrition and associated factors among aged residents in all nursing homes in Helsinki. Eur J Clin Nutr 2005; 59(4): 578–83PubMedCrossRef Suominen M, Muurinen S, Routasalo P, et al. Malnutrition and associated factors among aged residents in all nursing homes in Helsinki. Eur J Clin Nutr 2005; 59(4): 578–83PubMedCrossRef
27.
Zurück zum Zitat WHO. Guidelines for ATC classification and DDD assignment. Oslo: WHO Collaborating Centre for Drug Statistics Methodology, 1998 WHO. Guidelines for ATC classification and DDD assignment. Oslo: WHO Collaborating Centre for Drug Statistics Methodology, 1998
28.
Zurück zum Zitat Sink KM, Holden KF, Yaffe K. Pharmacological treatment of neuropsychiatric symptoms of dementia: a review of the evidence. JAMA 2005; 293(5): 596–608PubMedCrossRef Sink KM, Holden KF, Yaffe K. Pharmacological treatment of neuropsychiatric symptoms of dementia: a review of the evidence. JAMA 2005; 293(5): 596–608PubMedCrossRef
29.
Zurück zum Zitat Linjakumpu T, Hartikainen S, Klaukka T, et al. Psychotropics among the home-dwelling elderly: increasing trends. Int J Geriatr Psychiatry 2002; 17(9): 874–83PubMedCrossRef Linjakumpu T, Hartikainen S, Klaukka T, et al. Psychotropics among the home-dwelling elderly: increasing trends. Int J Geriatr Psychiatry 2002; 17(9): 874–83PubMedCrossRef
30.
Zurück zum Zitat Linden M, Bar T, Helmchen H. Prevalence and appropriateness of psychotropic drug use in old age: results from the Berlin Aging Study (BASE). Int Psychogeriatr 2004; 16(4): 461–80PubMedCrossRef Linden M, Bar T, Helmchen H. Prevalence and appropriateness of psychotropic drug use in old age: results from the Berlin Aging Study (BASE). Int Psychogeriatr 2004; 16(4): 461–80PubMedCrossRef
31.
Zurück zum Zitat Giron MS, Forsell Y, Bernsten C, et al. Psychotropic drug use in elderly people with and without dementia. Int J Geriatr Psychiatry 2001; 16(9): 900–6PubMedCrossRef Giron MS, Forsell Y, Bernsten C, et al. Psychotropic drug use in elderly people with and without dementia. Int J Geriatr Psychiatry 2001; 16(9): 900–6PubMedCrossRef
32.
Zurück zum Zitat Hughes CM, Lapane KL, Mor V. Influence of facility characteristics on use of antipsychotic medications in nursing homes. Med Care 2000; 38(12): 1164–73PubMedCrossRef Hughes CM, Lapane KL, Mor V. Influence of facility characteristics on use of antipsychotic medications in nursing homes. Med Care 2000; 38(12): 1164–73PubMedCrossRef
33.
Zurück zum Zitat Pitkala KH, Laurila JV, Strandberg TE, et al. Behavioral symptoms and the administration of psychotropic drugs to aged patients with dementia in nursing homes and in acute geriatric wards. Int Psychogeriatr 2004; 16(1): 61–74PubMedCrossRef Pitkala KH, Laurila JV, Strandberg TE, et al. Behavioral symptoms and the administration of psychotropic drugs to aged patients with dementia in nursing homes and in acute geriatric wards. Int Psychogeriatr 2004; 16(1): 61–74PubMedCrossRef
34.
Zurück zum Zitat Herrmann N, Mamdani M, Lanctot KL. Atypical antipsychotics and risk of cerebrovascular accidents. Am J Psychiatry 2004; 161(6): 1113–5PubMedCrossRef Herrmann N, Mamdani M, Lanctot KL. Atypical antipsychotics and risk of cerebrovascular accidents. Am J Psychiatry 2004; 161(6): 1113–5PubMedCrossRef
35.
Zurück zum Zitat Raivio MM, Laurila JV, Strandberg TE, et al. Psychotropic medication and stroke outcome. Am J Psychiatry 2005; 162(5): 1027–8PubMedCrossRef Raivio MM, Laurila JV, Strandberg TE, et al. Psychotropic medication and stroke outcome. Am J Psychiatry 2005; 162(5): 1027–8PubMedCrossRef
36.
Zurück zum Zitat Thorgrimsen L, Spector A, Wiles A, et al. Aroma therapy for dementia. Cochrane Database of Systematic Reviews 2003; (3): CD003150 Thorgrimsen L, Spector A, Wiles A, et al. Aroma therapy for dementia. Cochrane Database of Systematic Reviews 2003; (3): CD003150
37.
Zurück zum Zitat Burns A, Byrne J, Ballard C, et al. Sensory stimulation in dementia. BMJ 2002; 325(7376): 1312–3PubMedCrossRef Burns A, Byrne J, Ballard C, et al. Sensory stimulation in dementia. BMJ 2002; 325(7376): 1312–3PubMedCrossRef
38.
Zurück zum Zitat Spector A, Orrell M, Davies S, et al. Reality orientation for dementia. Cochrane Database of Systematic Reviews 2000; (4): CD001119 Spector A, Orrell M, Davies S, et al. Reality orientation for dementia. Cochrane Database of Systematic Reviews 2000; (4): CD001119
39.
Zurück zum Zitat Forbes DA. Strategies for managing behavioural symptomatology associated with dementia of the Alzheimer type: a systematic overview. Can J Nurs Res 1998 Summer; 30(2): 67–86PubMed Forbes DA. Strategies for managing behavioural symptomatology associated with dementia of the Alzheimer type: a systematic overview. Can J Nurs Res 1998 Summer; 30(2): 67–86PubMed
40.
Zurück zum Zitat Tariot PN. Medical management of advanced dementia. J Am Geriatr Soc 2003; 51 (5 Suppl. Dementia): S305–13PubMedCrossRef Tariot PN. Medical management of advanced dementia. J Am Geriatr Soc 2003; 51 (5 Suppl. Dementia): S305–13PubMedCrossRef
41.
Zurück zum Zitat Rosler M. The efficacy of cholinesterase inhibitors in treating the behavioural symptoms of dementia. Int J Clinical Pract Suppl 2002; (127): 20–36 Rosler M. The efficacy of cholinesterase inhibitors in treating the behavioural symptoms of dementia. Int J Clinical Pract Suppl 2002; (127): 20–36
42.
Zurück zum Zitat McKeith I, Del Ser T, Spano P, et al. Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study. Lancet 2000; 356(9247): 2031–6PubMedCrossRef McKeith I, Del Ser T, Spano P, et al. Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study. Lancet 2000; 356(9247): 2031–6PubMedCrossRef
43.
Zurück zum Zitat Tariot PN, Solomon PR, Morris JC, et al. A 5-month, randomized, placebo-controlled trial of galantamine in AD: the Galantamine USA-10 Study Group. Neurology 2000; 54(12): 2269–76PubMedCrossRef Tariot PN, Solomon PR, Morris JC, et al. A 5-month, randomized, placebo-controlled trial of galantamine in AD: the Galantamine USA-10 Study Group. Neurology 2000; 54(12): 2269–76PubMedCrossRef
44.
Zurück zum Zitat Elmstahl S, Stenberg I, Annerstedt L, et al. Behavioral disturbances and pharmacological treatment of patients with dementia in family caregiving: a 2-year follow-up. Int Psychogeriatr 1998; 10(3): 239–52PubMedCrossRef Elmstahl S, Stenberg I, Annerstedt L, et al. Behavioral disturbances and pharmacological treatment of patients with dementia in family caregiving: a 2-year follow-up. Int Psychogeriatr 1998; 10(3): 239–52PubMedCrossRef
Metadaten
Titel
Use of Psychotropic Drugs in Elderly Nursing Home Residents with and without Dementia in Helsinki, Finland
verfasst von
Helka Hosia-Randell
Dr Kaisu Pitkälä
Publikationsdatum
01.09.2005
Verlag
Springer International Publishing
Erschienen in
Drugs & Aging / Ausgabe 9/2005
Print ISSN: 1170-229X
Elektronische ISSN: 1179-1969
DOI
https://doi.org/10.2165/00002512-200522090-00008

Weitere Artikel der Ausgabe 9/2005

Drugs & Aging 9/2005 Zur Ausgabe

Review Article

Male Osteoporosis

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.